Autoimmune lymphoproliferative syndrome (ALPS) is an mTOR‐driven lymphoproliferative disorder that uniformly responds to sirolimus, suggesting involvement of mTORC1 in pathogenesis.8 Here, MTOR is linked to autoimmune lymphoproliferative syndrome.